Sonnet BioTherapeutics

-$0.06 (-3.85%) Today
-$0.02 (-1.33%) As of 10:35 AM UTC after-hours

Why Robinhood?

You can buy or sell SONN and other stocks, options, and ETFs commission-free!

About SONN

Sonnet BioTherapeutics Holdings, Inc. engages in the development of biologic drugs with enhanced single or bispecific mechanisms. Its technology utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues.

CEO
Pankaj Mohan
Employees
9
Headquarters
Princeton, New Jersey
Founded
2011

SONN Key Statistics

Market Cap
32.08M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.98M
High Today
$1.55
Low Today
$1.48
Open Price
$1.54
Volume
1.03M
52 Week High
$7.89
52 Week Low
$1.44

SONN Earnings

-$4.73
-$3.15
-$1.58
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Aug 16, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure